Applied Genetic Technologies to sell initial public offering of stock

Barclays and BMO Capital are the joint bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., Jan. 10 - Applied Genetic Technologies Corp. will price its initial public offering with a greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

Barclays and BMO Capital Markets are the joint bookrunning managers. Wedbush PacGrow Life Sciences, Cantor Fitzgerald and Roth Capital Partners are the co-managers.

Proceeds will be used for clinical trials and preclinical studies, working capital and other general corporate purposes.

The clinical-stage biotechnology company is based in Alachua, Fla. It intends to list its common stock on the Nasdaq under the symbol "AGTC."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.